Answer
Spironolactone should not be used during breastfeeding because its active metabolite canrenone enters human milk and effects on infants are insufficiently known; a decision to stop breastfeeding or discontinue or abstain from spironolactone must weigh breastfeeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- Aldactone 25mg TabletsPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 22Document updated
Sources checked